Dynavax Announces Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Dynavax (DVAX) Misses Q2 EPS by 10c
August 7, 2019 5:20 PM EDTDynavax (NASDAQ: DVAX) reported Q2 EPS of ($0.66), $0.10 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $8.3 million versus the consensus estimate of $9.14 million.
HEPLISAV-B net product revenue was $8.3 million for the second quarter of this year, which was in line... More
